Chen Xiao, Lu Xin-zhi, Gao Yan, Shi Xiao-chong, Yu Wen-gong
Institute of Marine Drugs and Foods, Ocean University of China, Qingdao 266003, China.
Yao Xue Xue Bao. 2004 Jan;39(1):13-6.
To investigate the antioxidant mechanisms of propylene glycol mannate sulfate (PGMS) in hyperlipidemic rats.
Male Wistar rats were given high lipid emulsion diet to establish hyperlipidemic model. PGMS was given every day at different doses (37.8 and 75.6 mg.kg-1, ig) to hyperlipidemic rats for three weeks. In addition, diethyldithiocarbamate (DDC) was given 200 mg.kg-1.3 d-1 (i.p.) to inhibit SOD activity. Then, the MDA content was examined using TBA method to show the oxidation level, and the activities of SOD, GSH-Px and CAT were examined following the kit protocols to indicate the capability of eliminating OFR. RT-PCR was applied to study the expression of Cu, Zn-SOD mRNA in rat liver.
The MDA content of PGMS treatment groups decreased markedly compared with hyperlipidemic group, and the activities of SOD, GSH-Px and CAT increased distinctly. Cu, Zn-SOD mRNA expression was significantly increased by PGMS treatment. Furthermore, the application of DDC(the SOD inhibitor) reduced total SOD activity and Cu, Zn-SOD mRNA expression induced by PGMS, and the content of MDA increased correspondingly.
PGMS can induce the activities of antioxidant enzymes and the mRNA expression of Cu, Zn-SOD, which contribute to the elimination of oxygen free radical. This may explain the molecular mechanism of antioxidant effects of PGMS.
探讨硫酸甘露聚糖丙二醇酯(PGMS)对高脂血症大鼠的抗氧化机制。
雄性Wistar大鼠给予高脂乳剂饲料以建立高脂血症模型。将不同剂量(37.8和75.6mg·kg-1,灌胃)的PGMS每日给予高脂血症大鼠,持续3周。此外,给予二乙基二硫代氨基甲酸盐(DDC)200mg·kg-1·3d-1(腹腔注射)以抑制超氧化物歧化酶(SOD)活性。然后,采用硫代巴比妥酸(TBA)法检测丙二醛(MDA)含量以显示氧化水平,并按照试剂盒说明书检测SOD、谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)活性以指示清除氧自由基(OFR)的能力。应用逆转录聚合酶链反应(RT-PCR)研究大鼠肝脏中铜锌超氧化物歧化酶(Cu,Zn-SOD)mRNA的表达。
与高脂血症组相比,PGMS治疗组的MDA含量显著降低,SOD、GSH-Px和CAT活性明显升高。PGMS治疗显著增加了Cu,Zn-SOD mRNA表达。此外,应用DDC(SOD抑制剂)降低了PGMS诱导的总SOD活性和Cu,Zn-SOD mRNA表达,MDA含量相应增加。
PGMS可诱导抗氧化酶活性及Cu,Zn-SOD的mRNA表达,有助于清除氧自由基。这可能解释了PGMS抗氧化作用的分子机制。